| Role |
Name |
Disclosure |
Details |
| Author | Donald A Person, MD, Medical Director, Senior Scientist, Department of Clinical Investigation, Tripler Army Medical Center, Honolulu; Professor of Pediatrics, F Edward Herbert School of Medicine, USUHS, John A Burns School of Medicine, University of Hawaii at Manoa | Nothing to disclose | Details | | Coauthor | Mandar A Pattekar, MD, MS, Consulting Staff, Department of Radiology, Methodist Hospital | Nothing to disclose | Details | | Pharmacy Editor | Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc | Pfizer Inc Avanir Pharma | Details | | Managing Editor | David D Sherry, MD, Professor of Pediatrics, Division of Rheumatology, University of Pennsylvania; Director of Clinical Rheumatology, Children's Hospital of Philadelphia | Nothing to disclose | Details | | CME Editor | Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine | Baxter Pfizer | Details | | Chief Editor | Barry L Myones, MD, Associate Professor, Departments of Pediatrics and Immunology, Pediatric Rheumatology Section, Baylor College of Medicine; Director of Research, Pediatric Rheumatology Center, Texas Children's Hospital | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Mandar A Pattekar, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| David D Sherry, Managing Editor |
The contributor discloses no conflict of interest. |
|